/
BBLG
$0.64+$0.02 (+2.48%)live
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Market cap
$1.2M
2M shares
52-week range
$0.62 – $4.13
1% from low
Sector
ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
Exchange
NASDAQ
CS
Change$-7328.93
Bone Biologics Corp Common Stock
Bone Biologics Corp a medical device company that is currently focused on bone regeneration in spinal fusion using the recombinant human protein known as NELL-1. NELL-1 in combination with DBM, demineralized bone matrix, is an osteopromotive recombinant protein that provides target specific control over bone regeneration. It is a clinical-stage entity. The production and marketing of its products and ongoing research and development activities are subject to extensive regulation by numerous governmental authorities in the United States.
www.bonebiologics.com- Employees
- 2
- IPO / List date
- Nov 27, 2015
- HQ
- BURLINGTON, MA
Held by traders on TradeandTell
No one on the platform currently holds BBLG.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in BBLG as of their last filing.
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2025-06-10 | 1-for-6reverse |
| 2023-12-20 | 1-for-8reverse |
| 2023-06-07 | 1-for-30reverse |
| 2021-10-13 | 1-for-2.5reverse |
| 2018-07-24 | 1-for-10reverse |
Recent trades on TradeandTell
No one on the platform has traded BBLG yet.
